
Silk Road Medical Investor Relations Material
Latest events

Q1 2024
Silk Road Medical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Silk Road Medical Inc
Access all reports
Silk Road Medical, Inc. is a medical device company that operates as a strategic niche player in its industry. The Company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization with devices under the Triangle MicroLaserTM and LaserCarotisTM brands, which include intracoronary stents, devices to deliver embolic protection during angiography, as well as other non-device related offerings intended to improve patient outcomes.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
SILK
Country
🇺🇸 United States